Bank of Montreal
ODT

Bank of Montreal’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Bank of Montreal’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$15K – 4408
2021
Q4 		$15K Hold
10,000
– – ﹤0.01% 3370
2021
Q3 		$31K Sell
10,000
-59,795
-86% -$199K ﹤0.01% 3612
2021
Q2 		$256K Buy
69,795
+69,334
+15,040% +$238K ﹤0.01% 3125
2021
Q1 		$2K Sell
461
-2,908
-86% -$55K ﹤0.01% 4949
2020
Q4 		$69K Buy
3,369
+2,763
+456% +$42.6K ﹤0.01% 3783
2020
Q3 		$10K Sell
606
-441
-42% -$12.5K ﹤0.01% 4150
2020
Q2 		$40K Buy
+1,047
New +$33.9K ﹤0.01% 3536
2020
Q1 		– Sell
-1,479
Closed -$48K – 4967
2019
Q4 		$48K Buy
1,479
+451
+44% +$14K ﹤0.01% 3861
2019
Q3 		$27K Buy
1,028
+373
+57% +$12.5K ﹤0.01% 3931
2019
Q2 		$24K Buy
655
+654
+65,400% +$15.7K ﹤0.01% 4084
2019
Q1 		$0 Sell
1
-95
-99% -$1.66K ﹤0.01% 4934
2018
Q4 		$1K Buy
96
+49
+104% +$763 ﹤0.01% 4597
2018
Q3 		$1K Sell
47
-1
-2% -$20 ﹤0.01% 4649
2018
Q2 		$1K Buy
+48
New +$1.12K ﹤0.01% 4639

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Bank of Montreal's ODT Position: Q1 2022 in Review

Bank of Montreal sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 10,000 shares — an estimated $15K sold.

Bank of Montreal first reported a position in ODT in Q2 2018 and held it in 14 quarters. The position peaked at $256K in Q2 2021. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • Bank of Montreal reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Bank of Montreal sold 10,000 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $15K.
  • Bank of Montreal first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2018 and held it in 14 quarters.
  • Bank of Montreal's Odonate Therapeutics, Inc. Common Stock position peaked at $256K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Bank of Montreal's 13F filing for Q1 2022, filed 12 May 2022.